Wall Street Zen Downgrades Wellgistics Health (NASDAQ:WGRX) to Sell

Key Points

• Wellgistics Health has been downgraded by Wall Street Zen from a "hold" rating to a "sell" rating.
• The company's stock opened at $1.50 and has seen a significant range over the past year, with a low of $0.62 and a high of $7.04.
• In its latest earnings report, Wellgistics Health reported a loss of ($0.11) earnings per share and revenue of $7.79 million for the quarter.

Wellgistics Health (NASDAQ:WGRX - Get Free Report) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a report issued on Saturday.

Wellgistics Health Stock Performance

NASDAQ:WGRX opened at $1.50 on Friday. The company has a quick ratio of 0.11, a current ratio of 0.32 and a debt-to-equity ratio of 11.16. The business has a fifty day moving average of $1.04. Wellgistics Health has a 12 month low of $0.62 and a 12 month high of $7.04.

Wellgistics Health (NASDAQ:WGRX - Get Free Report) last released its quarterly earnings data on Tuesday, August 19th. The company reported ($0.11) earnings per share for the quarter. The business had revenue of $7.79 million for the quarter.

About Wellgistics Health

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.